|1||Active, not recruiting||
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Multicenter Study of NAP (AL-108) in Schizophrenia
Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery
Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
† Study has passed its completion date and status has not been verified in more than two years.